BIOEQUIVALENCE OF FIXED-DOSE COMBINATIONS OF DAPAGLIFLOZIN/METFORMIN RELATIVE TO SINGLE COMPONENTS IN HEALTHY SUBJECTS

被引：0
|
作者：
Boulton, D. W. [1 ]
Chang, M. [1 ]
Griffen, S. C. [2 ]
Kitaura, C. [1 ]
Lubin, S. [1 ]
Pollack, A. [1 ]
LaCreta, F. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] JDRF, New York, NY USA
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.283
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E98 / E99
页数：2
相关论文
共 50 条
  • [1] Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability
    de Bruin, Tjerk W. A.
    Reele, Stots
    Hamer-Maansson, Jennifer E.
    Parikh, Shamik
    Tang, Weifeng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (02): : 118 - 130
  • [2] Bioequivalence and food effect assessment for vildagliptin/metformin fixed-dose combination tablets relative to free combinations of vildagliptin and metformin in Japanese healthy subjects
    Mita, Sachiko
    Chitnis, Shripad D.
    Kulmatycki, Kenneth
    Salunke, Atish
    Het, Yan-Ling
    Zhou, Wei
    Suzuki, Hikoe
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 305 - 314
  • [3] Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects
    Boulton, David W.
    Chang, Ming
    Griffen, Steven C.
    Kitaura, Catia
    Lubin, Susan
    Pollack, Allyson
    LaCreta, Frank
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 99 - 109
  • [4] A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects
    Okour, Malek
    Puri, Adeep
    Chen, Geng
    Port, Kathleen
    Berni, Alessandro
    Khindri, Sanjeev
    Schneider, Ian
    Tenero, David
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1110 - 1127
  • [5] Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects
    He, Y-L.
    Paladini, S.
    Sabia, H.
    Campestrini, J.
    Zhan, Y.
    Leon, S.
    Ligueros-Saylan, M.
    Jarugula, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (05) : 259 - 267
  • [6] Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects
    Chang, Ming
    Liu, Xiaoni
    Cui, Dapeng
    Liang, Dan
    LaCreta, Frank
    Griffen, Steven C.
    Lubin, Susan
    Quamina-Edghill, Donette
    Boulton, David W.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1517 - 1528
  • [7] Pharmacokinetics of fixed-dose combinations of empagliflozin/metformin compared with individual tablets in healthy subjects
    Rojas, Christina
    Link, Jasmin
    Meinicke, Thomas
    Macha, Sreeraj
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 282 - 292
  • [8] Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjects
    Vakkalagadda, Blisse
    Vetter, Marion L.
    Rana, Jignasa
    Smith, Charles H.
    Huang, Jian
    Karkas, Jennifer
    Boulton, David W.
    LaCreta, Frank
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (06): : 1 - 12
  • [9] Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects
    Liu, Chao
    Cleton, Adriaan
    Sui, Yubin
    Liu, Yuwang
    Li, Jinyi
    Yuan, Fei
    Sheng, Lei
    Xu, Hongrong
    Li, Xuening
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (02): : 173 - 184
  • [10] Spectrophotometric Absorption Correction Methods for the Estimation of Fixed-Dose Combinations of Dapagliflozin and Metformin Hydrochloride
    Dalal, Deepak
    Kant, Ravi
    Attri, Kavita
    Sharma, Kiran
    Dhanawat, Meenakshi
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (01) : 291 - 296
12345